G1 Therapeutics Inc (NASDAQ: GTHX): Hunting Genuine Value In Market Debris
Currently, there are 51.50M common shares owned by the public and among those 42.75M shares have been available to trade. Insiders at the company have transacted a total of 22 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, […]
